Nidec Announces that Takisawa Consolidates Shares and Becomes a Wholly Owned Subsidiary of Nidec
Nidec Announces that Takisawa Consolidates Shares and Becomes a Wholly Owned Subsidiary of Nidec
Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) announced today that Takisawa Machine Tool Co., Ltd. (“Takisawa”) has passed a resolution at its extraordinary general meeting of shareholders held on January 12, 2024, to consolidate 900,000 of its common shares into one, and that the consolidation has taken effect today. With this share consolidation, Takisawa has become a wholly owned subsidiary of the Company.
The aforementioned share consolidation is based on the Company’s November 20, 2023 press release, “Notice Regarding the Completion of Purchase and Settlement of Tendered Shares Certificates, etc. in Tender Offer of Takisawa Machine Tool Co., Ltd. (Securities Code: 6121) and its Entry to Nidec Group,” which informed that Takisawa would become a subsidiary of the Company, and that squeeze-out procedures would be carried out to make Takisawa a wholly owned subsidiary of the Company.
Takisawa is already deepening its ties with the Nidec Group in a variety of areas including management, business, and administration. Going forward, to achieve the target of becoming the world’s leading comprehensive machine tool manufacturer, the Nidec Group will make decisions swiftly for Takisawa and manage it efficiently for its businesses’ expansion and growth.
Teruaki Urago
General Manager
Investor Relations
+81-75-935-6140
ir@nidec.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201532499/en/
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
What the Fed’s QT Program Is, and Why Its End Matters
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?